Pharmaceuticals News and Research

RSS

BATSK advances 0.3% stock this week in the U.S.

BATS Global Markets, a global stock market operator, reports the BATS 1000 Index advanced 0.3% for the week ending March 4 in the U.S. The S&P 500 Index was up 0.1% for the same period.

5 Mar 2011

Deal Search Online: Pharma is the single most active sector in decade's health care M&A market

According to Deal Search Online, an Irving Levin Associates M&A database, there has been a total of 1,431 pharmaceutical M&A deals, totaling $632.3 billion dollars committed to the industry during the ten-year period ended December 31, 2010.

5 Mar 2011

Biosante to purchase $25.1 million shares of common stock in registered direct offering

BioSante Pharmaceuticals, Inc. today announced that it has received commitments from several institutional investors to purchase $25.1 million of securities in a registered direct offering.

5 Mar 2011

University of Delaware to host scholarly symposium in honor of Richard F. Heck

On Thursday, May 26, the University of Delaware will host the scholarly symposium "Frontiers in Catalysis" in honor of Richard F. Heck, Willis F. Harrington Professor Emeritus of Chemistry and Biochemistry, and winner of the 2010 Nobel Prize in Chemistry.

5 Mar 2011

Grifols receives FDA approval for Alphanate to treat vCJD

Grifols, a global healthcare company and biopharmaceutical manufacturer based in Barcelona, Spain today announced that it received approval from the US Food and Drug Administration for revised labeling for Alphanate Antihemophilic Factor/von Willebrand Factor Complex indicating that certain manufacturing steps have been shown to reduce the infectivity of a experimental TSE agent that is a model for variant Creutzfeldt Jakob Disease.

5 Mar 2011

Scientific symposium to examine new approaches to schizophrenia drug development

Despite significant investment in research and development by pharmaceutical companies, the last decade has seen a marked decline in the number of drugs developed and approved for schizophrenia. A multi-day symposium at the New York Academy of Sciences on Wednesday, March 9 - Friday, March 11 will convene world-leading experts in clinical, translational, and basic neuroscience to address this problem by examining novel, state-of-the-art approaches to schizophrenia drug development.

5 Mar 2011

Questcor Pharmaceuticals appoints BDO to audit its consolidated financial statements

Questcor Pharmaceuticals, Inc. has completed a formal selection process and appointed BDO USA, LLP as its independent, registered public accounting firm for the auditing of Questcor's consolidated financial statements.

5 Mar 2011

New HQ of David H. Koch Institute for Integrative Cancer Research officially dedicated

The new seven-story headquarters of the David H. Koch Institute for Integrative Cancer Research at MIT, where scientists and engineers are working together to pursue new ways to treat, detect and prevent cancer, will be officially dedicated today at 4 p.m.

5 Mar 2011

Researchers use qMRI to confirm effect of CS treatment in patients with OA

A group of Canadian researchers led by Prof. Jean-Pierre Pelletier, Head of the Osteoarthritis Research Unit at the University of Montreal Hospital Research Centre, published a clinical trial in which they confirm, for the first time using quantitative Magnetic Resonance Imaging, the disease modifying effects of chondroitin sulphate, a symptomatic slow acting drug for osteoarthritis.

5 Mar 2011

Eveo to develop mobile solutions that encourage adherence

Medication non-adherence is as dangerous and costly as many diseases, causing up to 125,000 deaths annually in the U.S. Non-adherence, the failure to take drugs on time in the dosages prescribed, has been described as the world's "other drug problem."

5 Mar 2011

CRF Health to present on ePRO data collection methods at DIA EuroMeeting

CRF Health, a leading global provider of ePRO solutions for the Life Sciences Industry will be joined by industry colleagues at the DIA EuroMeeting for a session on the topic ePRO data collection methods.

5 Mar 2011

State roundup: After Vinson stay, Alaska to implement health law

After allowing the application deadline to pass for $1 million in federal health care assistance, Alaska Gov. Sean Parnell said Thursday he will begin implementing the new health care law after all, now that a Florida judge has told the states to do just that.

5 Mar 2011

Redpoint Bio fourth quarter revenues are $0.7 million for 2010

Redpoint Bio Corporation, a company focused on the development of healthier foods and beverages and new approaches to the treatment of diabetes and obesity, today announced financial and operational results for the quarter and year ended December 31, 2010.

5 Mar 2011

Pediatrician unveils latest findings of IMPAACT HIV/AIDS study during 2011 CROI

A clinical study of anti-HIV/AIDS medicines in the developing world is on the verge of turning "the whole treatment world on its head," according to Dartmouth pediatrician Paul Palumbo.

4 Mar 2011

Protesters call on Indian government to reject free trade agreement with EU

Thousands of HIV-positive people from India and across Asia marched in New Delhi on Wednesday to protest the proposed free trade agreement between the European Union and India, "which has provisions that would restrict access to affordable medicines," the Times of India reports.

4 Mar 2011

New promising detection technology identifies cancer cells early

Yesterday's Wall Street Journal (March 1) published a lead article on page D1 entitled "Researchers Create Better Ways To Spot Cancer Cells", which described the research by Dr. Edward R. Flynn, of Senior Scientific LLC. The article was authored by Shirley S. Wang.

4 Mar 2011

President's bioethics commission names international panel to review whether U.S. rules protect clinical trial participants in U.S., abroad

"Prompted by concerns about an unethical U.S.-sponsored study in the 1940s," the Presidential Commission for the Study of Bioethical Issues on Tuesday announced the formation of an international panel "that will examine whether current rules adequately protect volunteers in global clinical trials," Science's "ScienceInsider" blog reports.

4 Mar 2011

BioSante vaccine increases median survival of resected pancreatic cancer patients

BioSante Pharmaceuticals, Inc. today announced publication of results from a Phase II clinical study that show BioSante's Pancreas Cancer Vaccine increased the median survival of resected pancreatic cancer patients from 15 to 20 months, as reported in published data, to 24.8 months, an increase of more than 25 percent.

4 Mar 2011

Shire receives European Commission approval for self-administration of FIRAZYR for HAE

Shire plc, the global specialty biopharmaceutical company, today announced that the European Commission has approved FIRAZYR for self-administration after training in subcutaneous injection technique by a healthcare professional. FIRAZYR is the first and only treatment for acute Type I and Type II hereditary angioedema (HAE) attacks licensed for self-administration in Europe.

4 Mar 2011

Researchers demonstrate potential neurochemical mechanism of weight loss

An interdisciplinary group of researchers at the University of Pennsylvania has, for the first time, identified the neurological and cellular signaling mechanisms that contribute to satiety - the sensation of feeling full - and the subsequent body-weight loss produced by drugs used to treat type 2 diabetes. More comprehensive knowledge of these mechanisms could form the basis for anti-obesity medications.

4 Mar 2011

Pharmaceuticals News and Research

BATSK advances 0.3% stock this week in the U.S.

Deal Search Online: Pharma is the single most active sector in decade's health care M&A market

Biosante to purchase $25.1 million shares of common stock in registered direct offering

University of Delaware to host scholarly symposium in honor of Richard F. Heck

Grifols receives FDA approval for Alphanate to treat vCJD

Scientific symposium to examine new approaches to schizophrenia drug development

Questcor Pharmaceuticals appoints BDO to audit its consolidated financial statements

New HQ of David H. Koch Institute for Integrative Cancer Research officially dedicated

Researchers use qMRI to confirm effect of CS treatment in patients with OA

Eveo to develop mobile solutions that encourage adherence

CRF Health to present on ePRO data collection methods at DIA EuroMeeting

State roundup: After Vinson stay, Alaska to implement health law

Redpoint Bio fourth quarter revenues are $0.7 million for 2010

Pediatrician unveils latest findings of IMPAACT HIV/AIDS study during 2011 CROI

Protesters call on Indian government to reject free trade agreement with EU

New promising detection technology identifies cancer cells early

President's bioethics commission names international panel to review whether U.S. rules protect clinical trial participants in U.S., abroad

BioSante vaccine increases median survival of resected pancreatic cancer patients

Shire receives European Commission approval for self-administration of FIRAZYR for HAE

Researchers demonstrate potential neurochemical mechanism of weight loss

Event guide: World ADC San Diego eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence